Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases. Now, researchers have taken the first steps in developing a chemotherapy for melanoma that can be “painted” directly on the skin, rather than injected or taken orally.
They report their results in ACS Nano.
According to the Skin Cancer Foundation, melanoma is the deadliest form of cancer because of its tendency to spread, or metastasize, from the skin to other parts of the body. Common treatments include surgery, radiation therapy and intravenous chemotherapy, but these can cause pain or unpleasant side effects. If scientists could find a way to administer chemotherapy through the skin, they could target the treatment directly to the tumor site and possibly avoid side effects. Bingfang He, Ran Mo and colleagues wanted to develop a gel that patients themselves could apply to a skin tumor. But first they had to figure out how to get the therapy to penetrate deep within the skin.
For this purpose, the researchers assembled nanoparticles called “transfersomes,” which consist of a phospholipid bilayer and surfactants that encapsulate drugs or other molecules — in this case, the chemotherapy drug paclitaxel. The surfactants made the particles more deformable so that they could better infiltrate the skin; these compounds also affected the lipid matrix of the skin to help the particles more easily pass. The researchers added a peptide to the surface of the transfersome to further help the particle penetrate the skin, as well as enter tumor cells. To increase the time that the transfersomes persisted on skin, the researchers embedded the nanoparticles into a hydrogel. Then, they painted the gel on tumors of melanoma-bearing mice once a day, in combination with intravenous administration of paclitaxel every other day. After 12 days, the tumors of these mice were about half the size of tumors in mice treated with intravenous paclitaxel alone, suggesting that the transfersome gel helped slow tumor growth.
Receive an email update when we add a new MELANOMA article.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
Study Demonstrating Accuracy of DecisionDx-Melanoma Prognostic Test Across Melanoma Tissue Sources Presented at the American Society of Dermatopathology 55 th Annual Meeting
on November 13, 2018 at 3:00 am
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced study results ... […]
Kirkwood Helped Chart Course of Adjuvant Immunotherapy in Melanoma
on November 12, 2018 at 8:58 am
For a time, John M. Kirkwood, MD, thought he might become a professional musician. His mother, 2 sisters, and 2 brothers have worked as professional musicians, and he was as fascinated with music as h... […]
Immunotherapy drug helps patients with metastatic melanoma
on November 12, 2018 at 5:22 am
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkp... […]
SITC18: Nektar’s NKTR-214 holds steady in melanoma combination trial with BMS’ Opdivo
on November 9, 2018 at 2:15 pm
Following data earlier this year that saw flagging overall response rates in late-stage melanoma, Nektar Therapeutics unveiled new, highly anticipated clinical results for its combination of NKTR-214 ... […]
Adjuvant Options Arrive for Melanoma
on November 8, 2018 at 1:04 pm
The treatment armamentarium for adjuvant melanoma has expanded rapidly, which has left the treatment challenge of selecting between immunotherapy and targeted therapy without any head-to-head comparat... […]
New Guidelines for Early-Stage Melanoma Treatment
on November 8, 2018 at 11:04 am
The American Academy of Dermatology has published a new clinical practice guidelines with recommendations for the treatment of patients with primary cutaneous melanoma. The guidelines includes best pr... […]
New BRAF insight sheds light on strategy against drug-resistant melanoma
on November 7, 2018 at 4:58 am
Combinations of BRAF inhibitor and MEK inhibitor have been widely used to treat melanoma, but some patients quickly develop resistance to the treatment. Now, scientists at Thomas Jefferson University’ ... […]
How melanoma evades targeted therapies
on November 6, 2018 at 8:02 am
Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0 Melanoma is the leading cause of death from skin cancer. […]
Men's Melanoma Death Rates Rising, Women's Steady or Falling
on November 6, 2018 at 7:26 am
According to research presented at the 2018 NCRI Cancer Conference in Glasgow, the rate of men dying from malignant melanoma has risen around the world, while in some countries the rates are steady or ... […]
via Bing News